Nettet6. des. 2024 · Find the latest Intellia Therapeutics, Inc. (NTLA) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance Nettet14. jul. 2024 · During the first quarter of 2024, Intellia reported total operating expenses of about $46 million and a net loss of $31.8 million. The company had $250.3 million in …
Intellia Therapeutics Shares Soar 12% on Positive Analyst Rating …
Nettet1. jul. 2024 · Intellia Therapeutics stock declined 4.0% the last twenty-one trading days (one month), compared to a broader market (S&P500) rise of 1.1%. A change of -4% or more over twenty-one trading days is ... Nettet13. apr. 2024 · Intellia Therapeutics Stock Performance. 3 Mid-Caps That Could Double in 2024; Shares of NTLA opened at $34.58 on Thursday. The stock has a fifty day moving average price of $39.20 and a 200 day moving average price of $43.29. Intellia Therapeutics, Inc. has a 12 month low of $32.44 and a 12 month high of $76.45. learn to trade the stock market
What’s Next For Alnylam Stock After The Recent Positive ... - Forbes
NettetIntellia Therapeutics, Inc. (NTLA) Stock Price, News, Quote & History - Yahoo Finance U.S. markets closed S&P 500 +14.64 Dow 30 33,485.29 +2.57(+0.01%) Nasdaq 12,087.96 +91.09(+0.76%) Russell... Find the latest Intellia Therapeutics, Inc. (NTLA) stock discussion in Yahoo … Discover historical prices for NTLA stock on Yahoo Finance. View daily, weekly or … Find the latest Intellia Therapeutics, Inc. (NTLA) stock quote, history, news and … Find out the direct holders, institutional holders and mutual fund holders for … See Intellia Therapeutics, Inc. (NTLA) Environment, Social and Governance … See the company profile for Intellia Therapeutics, Inc. (NTLA) including … The latest news and headlines from Yahoo! News. Get breaking news stories and in … See Intellia Therapeutics, Inc. (NTLA) stock analyst estimates, including earnings … Nettet24. mar. 2024 · Intellia Therapeutics (NASDAQ: NTLA) is a biotechnology company using CRISPR gene-editing technology to develop several experimental drugs, many of with having the potential to save countless lives. As a relatively new drug development technology, Intellia is one of several companies at the forefront of CRISPR-based drug … Nettet12/19/21 NTLA Intellia Therapeutics, Inc. ( NASDAQ:NTLA ) Sector: Health Technology (Biotechnology) Market Capitalization: 9.545B Current Price: $128.23 Breakout price: $125.25 (hold above) Buy Zone (Top/Bottom Range): $118.80-$110.25 Price Target: $170.00-$174.00 Estimated Duration to Target: 84-90d Contract Intellia Therapeutics, … how to do order of operation math